Clinical investigator and regenerative medicine pioneer Don Buford, MD, is leading the charge to bring the latest advances in mechanobiology and regenerative medicine to 32.5 million knee arthritis sufferers across the United States in a National Institutes of Health-funded study aimed at reducing opioids and surgery.

Reveal Pharmaceuticals doses first subjects in Phase 1 Clinical Trial of RVP-001

Dr. Nuria Carrillo joins the Staff at Top Patient Advocacy organization for GNE Myopathy

Woman-owned GovCon leader specializing in technology and services for federal health, science programs expands ongoing support to National Institutes of Health (NIH)

COVID-19 - The letter to the VP for Research

The Designer Drug Research Unit at the National Institute on Drug Abuse will conduct research on CaaMTech's library of tryptamine-based compounds

Inspirotec, Inc. announced today that their currently available commercial air sampling device, AirAnswers, has the capability to detect viruses in the air and potentially Covid 19.

With $4.8 million from the NIH, Gladstone scientists will investigate how the protein apoE4 causes neurodegeneration in Alzheimer's disease.

Small Business Set Aside Boasts $45M Ceiling

New publication Industry-Sponsored Research Management helps universities offset cuts to federal funding by building corporate partnerships

Li Gan, PhD, a senior investigator at Gladstone, was awarded a multi-million dollar grant by the National Institute of Neurological Disorders and Stroke (NINDS) to lead a national collaboration studying how the protein tau contributes to frontotemporal dementia.

Seattle Biotech SpringStar awarded NIH Small Business Innovative Research Grant to commercialize groundbreaking trap for Zika carrying mosquitoes

The meeting highlighted Lazarex Cancer Foundation's new iMPACT pilot program, which is working to improve patient enrollment, retention, and minority member participation in oncology clinical trials especially among underserved populations.

TypeZero's inControl AP platform will revolutionize diabetes management for many Type 1 patients around the world.

Many cancer survivors find that once treatment ends, transitioning to a new way of life can be hard. Browse advice and resources on life after cancer treatment.

VBS announced the award of a $1.2 million, milestone-based, 3-year contract from the National Heart Lung Blood Institute (NHLBI) of the National Institutes of Health (NIH) to expedite the development of CAR therapeutic peptide pulmonary hypertension

The National Institutes of Health awards $300,000 to Agile Sciences

New hires bring significant expertise and grant funding to the region

Dr. Kongnara Papangkorn's presentation is entitled,"Safety Aspects and Drug Delivery Performance of Visulex® Passive Delivery System"

UofL-led consortium includes Johns Hopkins, Emory and VCU to study cardioprotective therapies

PolyMedix, Inc, has received a Phase 2 grant in the amount of $986,000 from the National Institute of Health (NIH) to support the development of defensin mimetic antimicrobial compounds for the treatment of oral candidiasis.

U.S. Commerce, NIH, and NSF partner to recognize Innovative projects to boost Economic Development

Diabetica Research Solutions, Inc. (DRSI) announces the formation of its Diabetes Healthcare Advisory Board. Richard Corlin M.D., FACP, will serve as Chairman, and other members include D. Walter Cohen D.D.S., Joyce Malaskovitz PhD., R.N., C.D.E.,

Aciont is awarded a phase I SBIR $214K grant for the project titled "Novel Method for the Ocular Iontophoretic Delivery of Avastin® and Lucentis®"

eMedonline® personalized drug management and optimization system is being used to improve Gleevec therapy at Rex Cancer Center. The system is implemented as a "smart service" that leverages the wireless capabilities of RFID and cellphone technol